MedPath

Endomagnetics, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

Not Applicable
Recruiting
Conditions
Breast Cancer
Axillary Lymph Nodes
First Posted Date
2019-01-08
Last Posted Date
2024-08-12
Lead Sponsor
Endomagnetics Inc
Target Recruit Count
65
Registration Number
NCT03796559
Locations
🇺🇸

Baylor Medicine, Houston, Texas, United States

🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

Magseed Magnetic Marker Localization

Not Applicable
Completed
Conditions
Disorders of Breast
Breast Lesions
First Posted Date
2017-01-13
Last Posted Date
2021-02-04
Lead Sponsor
Endomagnetics Inc
Target Recruit Count
120
Registration Number
NCT03020888
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

SentiMag® Intraoperative Comparison in Breast Cancer

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Device: SiennaXP
Drug: Isosulfan blue dye
First Posted Date
2015-01-13
Last Posted Date
2020-11-23
Lead Sponsor
Endomagnetics Inc
Target Recruit Count
160
Registration Number
NCT02336737
Locations
🇺🇸

University of California San Diego Moores Cancer Center, La Jolla, California, United States

🇺🇸

University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

🇺🇸

UCSF Carol Franc Buck Breast Care Center, San Francisco, California, United States

and more 3 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.